VaR

(redirected from VAD)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

VaR

Value at Risk

In risk analysis, a method to measure the probability of loss on an investment. One calculates the value at risk by measuring the historical trends and volatility of the investment. The method is used most often by investors in highly volatile commodities, such as energy products.
Mentioned in ?
References in periodicals archive ?
Lily Burnell was one of a group of younger women recruited around the time the VAD hospital opened in Southam.
the company that makes and sells the HeartMate II, a type of VAD, estimates that between 50,000 and 100,000 advanced heart failure patients in the United States would benefit from a VAD.
With the benefit of more recent, smaller-sized devices, VAD explants can be carried out by simply removing the pump through a subcostal incision, occluding the ventriculotomy with a plug (i.
The Levacor VAD was initially developed at and spun-off from the University of Utah and is being commercialized by WorldHeart Corporation, a Salt Lake City-based company.
Lewis said, "Our products will scale from small companies to large companies, but we sell mostly to the mid-market, and I think that fits with Metro VAD as well.
The Levacor VAD is the only fully magnetically levitated, bearingless, implantable centrifugal pump to move into clinical trial.
In addition to the IVAD trial, Thoratec currently has a Premarket Approval (PMA) Supplement for its TLC-II Portable VAD Driver before the FDA and says it hopes to receive approval to market the device this quarter.
The Joint Commission, in its most recent evaluation of Mayo's VAD program, gave high marks to the program.
Craig Selzman, cardiac surgeon and the University of Utah's surgical Principal Investigator for the study commented, "We are excited to participate in the Levacor VAD BTT Study and to provide a unique technology to our patients.
This study reports on the results of the first 100 patients with AMI cardiogenic shock and implanted with the AB5000 VAD.
6 million, 4-year contract by the National Institutes of Health (NIH) to further develop the PediaFlow(TM) VAD to clinical trial readiness.
stroke) related to their treatment or their underlying disease and request withdrawal of VAD support.